Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) remain a clinical challenge due to limited treatment options. Recently, cefiderocol, a novel siderophore cephalosporin, and sulbactam-durlobactam, a bactericidal β-lactam–β-lactamase inhibitor combination, ha...

Полное описание

Библиографические подробности
Главные авторы: Arta Karruli, Antonella Migliaccio, Spyros Pournaras, Emanuele Durante-Mangoni, Raffaele Zarrilli
Формат: Статья
Язык:English
Опубликовано: MDPI AG 2023-12-01
Серии:Antibiotics
Предметы:
carbapenem-resistant <i>Acinetobacter baumannii</i>
cefiderocol
sulbactam-durlobactam
antimicrobial susceptibility
mechanisms of resistance
antimicrobial therapy
Online-ссылка:https://www.mdpi.com/2079-6382/12/12/1729

Internet

https://www.mdpi.com/2079-6382/12/12/1729

Схожие документы